Medical Equipment

Hemostats Industry Growth Insights: Revenue Forecast to 2030

February 5, 2026February 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Hemostats Market between 2026 and 2030?

The hemostats market has observed robust expansion in recent years. This market is projected to grow from $3.56 billion in 2025 to $3.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be ascribed to a rising number of surgical procedures, the enhancement of hospital surgical infrastructure, developments in biomaterial technologies, an increasing need for effective blood loss management, and the broader acceptance of minimally invasive surgeries.

The hemostats market size is projected to experience substantial expansion over the upcoming years, reaching $5.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from a heightened emphasis on patient safety outcomes, a growing need for quicker surgical recovery, the proliferation of advanced trauma care facilities, continuous innovation in bioactive hemostatic materials, and the increasing uptake of specialized surgical products. Key developments anticipated in this period encompass the expanded application of sophisticated combination hemostats, the rising acceptance of ready-to-use hemostatic agents, an escalating requirement for solutions that enable rapid bleeding control, the broader availability of biocompatible and absorbable products, and an intensified focus on improving surgical efficiency and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8226&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Hemostats Market?

The hemostat market is anticipated to grow due to an escalation in surgical procedures. These procedures encompass all invasive medical treatments performed to diagnose or address a disease state. Hemostats are vital in surgery for their role in preventing blood loss during operations. For instance, in June 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that minimally invasive procedures increased by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Additionally, hand surgeries for conditions such as carpal tunnel, arthritis, and trigger finger collectively reached 207,887 procedures, reflecting a 2% rise from 2022. Therefore, the expanding volume of surgical interventions is driving the hemostat market’s growth. The increasing occurrence of trauma cases is projected to drive the expansion of the haemostat market. A trauma case refers to any medical emergency resulting from an external force injury that necessitates urgent assessment and treatment. This rise in trauma incidents is primarily fueled by an increase in road accidents, where higher traffic volume and unsafe driving behaviors contribute to severe injuries requiring prompt medical attention. Hemostats are crucial in trauma situations for their ability to rapidly control bleeding at the injury site, allowing clinicians to stabilize patients more quickly and improve overall survival outcomes. For example, the Alaska Department of Health, a US-based government agency, stated in October 2024 that approximately 3,373 individuals in Alaska sustained traumatic brain injuries (TBI) in 2023, a figure that includes both fatal cases and non-fatal injuries treated and released from hospitals or emergency departments (EDs). Consequently, the growing prevalence of trauma cases is propelling the growth of the haemostat market.

How Is The Hemostats Market Organized Into Various Segments?

The hemostats market covered in this report is segmented –

1) By Composition: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats

2) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products

3) By Formulation: Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats

4) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications

Subsegments:

1) By Thrombin-Based Hemostats: Topical Thrombin, Lyophilized Thrombin

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads, Granules

3) By Combination Hemostats: Thrombin And Gelatin Combinations, Thrombin And Collagen Combinations

4) By Gelatin-Based Hemostats: Gelfoam, Gelatin Sponge

5) By Collagen-Based Hemostats: Collagen Sheets, Collagen Powder

Which Trends Are Expected To Influence The Hemostats Market In The Upcoming Years?

Leading firms in the Hemostat market are deliberately forming alliances and partnerships with emerging and medium-sized enterprises to expand their range of products and services. These strategic alliances and cooperative agreements enable businesses to enlarge their current product offerings and extend their global presence. A notable example occurred in May 2023, when Olympus, a Japan-based manufacturer of optics and reprography products, deepened its collaboration with Endoclot, a US-based medical device company, to introduce hemostatic agents. Incorporating these solutions into Olympus’s portfolio facilitates its contribution to secure treatments within gastrointestinal procedures. The primary objective of this joint venture is to enhance patient results and consequently raise the overall standard of medical care.

Who Are The Top-Performing Companies In The Hemostats Market In Recent Years?

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom’up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Which Region Currently Holds The Largest Share Of The Hemostats Market?

North America was the largest region in the hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemostats Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8226&type=smp

Browse Through More Reports Similar to the Global Hemostats Market 2026, By The Business Research Company

Hemostasis Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Surgical Sealants And Adhesives Market 2026

https://www.thebusinessresearchcompany.com/report/surgical-sealants-and-adhesives-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795